Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Translational Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1637091

Utilizing Group-Based Models to Identify Adverse Event Patterns After an Intervention

Provisionally accepted
  • 1Brigham and Women's Hospital, Boston, United States
  • 2Massachusetts General Hospital, Harvard Medical School, Boston, United States

The final, formatted version of the article will be published soon.

Background: Standard adverse event (AE) monitoring only records whether an event has occurred after the intervention, and not whether these events vary over time.Objective: To test whether there were statistically distinct time-varying trajectories of AE (e.g., "side effects") after an intervention and identify characteristics of individuals associated with these patterns.Design: Group-based trajectory models applied to an observational study of individuals who received one or two doses of a mRNA COVID-19 vaccine (i.e., the intervention).Participants: 50,484 healthcare personnel who received their vaccinations within the Mass General Brigham (MGB) healthcare system.Main Measures: Allergic and non-allergic AE for 1-3 days after each of two COVID-19 vaccinations.Key Results: Trajectories models identified distinct groups with different trajectories after intervention: two groups after the first vaccination and five groups after the second vaccination. These groups differed by demographics, age, prior prescription for epinephrine auto-injectors, prior COVID-19 history, time-ofday of vaccination, and vaccine manufacturer.Conclusions: Several different time-based trajectories after the intervention (e.g., first two COVID-19 vaccinations) were noted; individuals in these groups varied by demographic and clinical criteria. These time-based methods may be able to identify groups at higher risk of future adverse reactions, provide a basis for future studies of the physiology underlying these risk differentials, and improve counseling surrounding interventions associated with AEs. We suggest that trajectory-based methods be added to post-intervention surveillance.

Keywords: Side-effects, adverse events, trajectory analyses, COVID-19 adverse effects monitoring, Vaccines, adverse effects following immunization (AEFI) Study type: Original research Trial Registration: Not required (Retrospective Analysis)

Received: 28 May 2025; Accepted: 11 Aug 2025.

Copyright: © 2025 Wang, Abbaspour, Blumenthal, Hashimoto, Robbins and Klerman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Elizabeth B Klerman, Massachusetts General Hospital, Harvard Medical School, Boston, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.